Nucleoside analogues
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Nucleoside analogues, covering 2016-01-13 to 2016-01-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Early Immunologic Response in Asian Patients With Chronic Hepatitis B, Treated With Pegasys (Peginterferon Alfa-2a (40KD)), Nucleoside Analogues, or Both [Phase 1]